In today’s complex deal environment, it is vital that you don’t have any accounting surprises from your licencing or partnering arrangements and that you understand the post-tax value of your transactions. Our panel of biopharma partnering experts from Taylor Wessing and EY, in conjunction with One Nucleus, will share practical tips and strategies designed to help you with those transactions so that you can structure them as optimally as commercially possible.
 
This session will cover:
 
•    Common pitfalls and best practices in cross-border licensing arrangements (including what to put in the agreement).
•    Approaches to structuring deals with a focus on net benefit retention.
•    Practical guidance on the impact of R&D tax credits, patent box benefits, and other incentives to help you ensure you maximise your tax claims appropriately and so mitigate your effective tax rate. 

Whether you are negotiating new collaborations or managing existing alliances, this event offers actionable insights to enhance value creation across your portfolio.

We hope you can join us for what promises to be an engaging and informative discussion. 

Following the discussion, there will be a Sandwich lunch and opportunity to watch the Autumn Budget Statement live.

To request an invite please email [email protected].